 The recommended uniform screening panel, RUSP, includes seven conditions recommended by the U.S. Secretary of Health and Human Services for Inclusion and State Newborn Screening, NBS Severe Combined Immunodeficiency, SCID, Critical Congenital Heart Disease, CCHD, Glycogen Storage Disease, Type II, POMPA, Mucopolysacredosis, Type I, MPSI, X-linked Adrenalucidistrophy, XALD, Spinal Muscular Atrophy, SMA, and Mucopolysacredosis, Type II, MPS II. The adoption of SCID and CCHD newborn screening by programs in all 50 states and three territories, Washington D.C., Guam, and Puerto Rico, took approximately eight and six years, respectively. As of December 2022, 37 programs screened for POMPA, 34 for MPSI, 32 for XALD, and 48 for SMA. The rate of implementation based on the average additional number of NBS programs per year was fastest for SMA. This article was authored by Shikha Singh, Jelalayo Jodoo, Alex or Kemper, and others. We are article.tv, links in the description below.